✳flâneur — a map of the web's best reading

Healthcare M&A 2024: Recent Deals and Trends

finalis.com · 81 words · saved by 1 readers

Tailored for healthcare enthusiasts, this article provides insights from experts on the dynamic landscape of healthcare M&A. Learn about the latest healthcare M&A deals and gain valuable insights relevant to investment bankers in the capital markets. Kaufman Hall, a healthcare management consulting firm, reported a notable uptick in healthcare M&A deals in Q1 2024 compared to the previous three quarters. This finding was reinforced by an article from Leerink Partners, a prominent investment bank catering to healthcare and life science companies focused on innovation and growth. In their article published on April 16, 2024, Leerink Partners affirmed that Healthcare M&A activity maintained its strength in Q1 2024, with 29 transactions recorded, up from 28 in Q1 2023. According to Dealogic data on healthcare M&A deals, within the 29 transactions recorded year-to-date in 2024, biopharma accounted for 13, services for 10, MedTech for 4, life sciences tools/diagnostics for 2, and healthcare

Healthcare M&A 2025: Recent Deals and Trends | Finalis Blog Resources Events Company Pricing Log in Get Started Today Related posts Back to blog Compliance The M&A Broker Exemption: Why It's Narrower Than Most Bankers Assume July 8, 2026 • 6 min read Investment Banking Are You Ready to Go Independent? 5 Questions Before You Jump June 19, 2026 • 3 min read Compliance Off the Grid: The Compliance Risks Some Independent Bankers Ignore June 12, 2026 • 6 min read

Explore this link on the map →

related reading